Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vectura Group Plc (VEC.LN)

Vectura Group Plc (VEC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vectura Group Plc One Prospect West Chippenham Wiltshire SN14 6FH GBR

www.vectura.com P: 124-966-7700 F: 124-966-7701

Description:

Vectura Group PLC is engaged in inhaled product formulation, device design and development business offering an integrated inhaled drug delivery platform. The company has developed inhalation products to help patients suffering from airways diseases. It has approx ten key inhaled and eleven non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development. The company's partners include Hikma, Novartis, Sandoz, Mundipharma, Kyorin, Baxter, GSK, UCB, Bayer, Chiesi, Almirall, Dynavax and Tianjin KingYork. The company operates in the United Kingdom, Japan, Switzerland, the United States of America, and Rest of the world with maximum revenue from the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 1,011,694
Shares Outstanding, K 613,892
Annual Sales, $ 190,600 K
Annual Net Income, $ 122,400 K
% of Insider Shareholders 0.97%
% of Institutional Shareholders 63.47%

Growth:

1-Year Return 58.77%
3-Year Return 139.53%
5-Year Return 21.35%
5-Year Revenue Growth 22.71%
5-Year Earnings Growth 77.85%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.20
Annual Dividend Yield 23.06%
Most Recent Dividend 0.190 on 06/01/21
Next Ex-Dividends Date 06/01/21
Dividend Payable Date 06/11/21
Dividend Payout Ratio 0.00%
Most Recent Split 5-6 on 06/01/21

VEC.LN Ratios

Ratio
Price/Earnings ttm 8.20
Price/Earnings forward 16.81
Return-on-Equity % 25.40%
Return-on-Assets % 20.46%
Profit Margin % 64.22%
Debt/Equity 0.01
Price/Sales 5.26
Price/Book 1.86
Book Value/Share 0.89
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar